In:
Annual Review of Medicine, Annual Reviews, Vol. 75, No. 1 ( 2024-01-27)
Abstract:
The porphyrias are a group of rare diseases, each resulting from a defect in a different enzymatic step of the heme biosynthetic pathway. They can be broadly divided into two categories, hepatic and erythropoietic porphyrias, depending on the primary site of accumulation of heme intermediates. These disorders are multisystemic with variable symptoms that can be encountered by physicians in any specialty. Here, we review the porphyrias and describe their clinical presentation, diagnosis, and management. We discuss novel therapies that are approved or in development. Early diagnosis is key for the appropriate management and prevention of long-term complications in these rare disorders. Expected final online publication date for the Annual Review of Medicine, Volume 75 is January 2024. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.
Type of Medium:
Online Resource
ISSN:
0066-4219
,
1545-326X
DOI:
10.1146/med.2024.75.issue-1
DOI:
10.1146/annurev-med-042921-123602
Language:
English
Publisher:
Annual Reviews
Publication Date:
2024
detail.hit.zdb_id:
1481484-5
Permalink
